Psoriasis : Psoriasis is a common, chronic relapsing/remittingimmune-mediated skin disease characterized by red, scaly patches, papules, and plaques, which usually itch. The skin lesions seen in psoriasis may vary in severity from minor localized patches to complete body coverage.[2] The disease affects 2–4% of the general population. There are five main types of psoriasis: plaque, guttate, inverse, pustular, anderythrodermic. Plaque psoriasis is the most common form and typically manifests as red and white scaly patches on the top layer of the skin. Skin cells rapidly accumulate at these plaque sites and create a silvery-white appearance. Plaques frequently occur on the skin of the elbows and knees, but can affect any area, including the scalp, palms of hands and soles of feet, and genitals. In contrast to eczema, psoriasis is more likely to be found on theouter side of the joint. Fingernails and toenails are frequently affected (psoriatic nail dystrophy) and can be seen as an isolated sign. Inflammation of the joints in the context of psoriatic disease, known as psoriatic arthritis, affects up to 30% of individuals with psoriasis. The causes of psoriasis are not fully understood. Psoriasis is not purely a skin disorder and can have a negative impact on many organ systems. Psoriasis has been associated with an increased risk of certain cancers, cardiovascular disease and other immune-mediated disorders such as Crohn's disease andulcerative colitis. It is generally considered a genetic disease thought to be triggered or influenced by environmental factors. Psoriasis develops when the immune system mistakes a normal skin cell for a pathogen, and sends out faulty signals that cause overproduction of new skin cells. It is not contagious. Oxidative stress, stress, and withdrawal of a systemiccorticosteroid have each been suggested as a trigger for psoriasis. Injury to the skin can trigger local psoriatic skin changes known as the Koebner phenomenon. No cure is available for psoriasis, but various treatments can help to control the symptoms. Though many treatments are available, psoriasis can be difficult to treat due to its chronic recurrent nature. A new generation of targeted immune therapies is being subjected to rigorous investigation in order to advance treatment options for psoriasis.


Eczema : Eczema is also known as atopic dermatitis, or atopic eczema (the most common form of eczema). Atopic eczema mainly affects children, but it can continue into adulthood or start later in life. Eczema symptoms include itchy, red, and dry skin caused by inflammation. It’s most commonly found in children, although adults can get it. It is also called atopic dermatitis and is treated with oral medications, steroid creams and light therapy . Drugs used Tacrolimus, Hydrocortisone, Dexamethasone, Prednisone


Psoriasis : Psoriasis is a common, chronic relapsing/remittingimmune-mediated skin disease characterized by red, scaly patches, papules, and plaques, which usually itch. The skin lesions seen in psoriasis may vary in severity from minor localized patches to complete body coverage.[2] The disease affects 2–4% of the general population. There are five main types of psoriasis: plaque, guttate, inverse, pustular, anderythrodermic. Plaque psoriasis is the most common form and typically manifests as red and white scaly patches on the top layer of the skin. Skin cells rapidly accumulate at these plaque sites and create a silvery-white appearance. Plaques frequently occur on the skin of the elbows and knees, but can affect any area, including the scalp, palms of hands and soles of feet, and genitals. In contrast to eczema, psoriasis is more likely to be found on theouter side of the joint. Fingernails and toenails are frequently affected (psoriatic nail dystrophy) and can be seen as an isolated sign. Inflammation of the joints in the context of psoriatic disease, known as psoriatic arthritis, affects up to 30% of individuals with psoriasis. The causes of psoriasis are not fully understood. Psoriasis is not purely a skin disorder and can have a negative impact on many organ systems. Psoriasis has been associated with an increased risk of certain cancers, cardiovascular disease and other immune-mediated disorders such as Crohn's disease andulcerative colitis. It is generally considered a genetic disease thought to be triggered or influenced by environmental factors. Psoriasis develops when the immune system mistakes a normal skin cell for a pathogen, and sends out faulty signals that cause overproduction of new skin cells. It is not contagious. Oxidative stress, stress, and withdrawal of a systemiccorticosteroid have each been suggested as a trigger for psoriasis. Injury to the skin can trigger local psoriatic skin changes known as the Koebner phenomenon. No cure is available for psoriasis, but various treatments can help to control the symptoms. Though many treatments are available, psoriasis can be difficult to treat due to its chronic recurrent nature. A new generation of targeted immune therapies is being subjected to rigorous investigation in order to advance treatment options for psoriasis.


Eczema : Eczema is also known as atopic dermatitis, or atopic eczema (the most common form of eczema). Atopic eczema mainly affects children, but it can continue into adulthood or start later in life. Eczema symptoms include itchy, red, and dry skin caused by inflammation. It’s most commonly found in children, although adults can get it. It is also called atopic dermatitis and is treated with oral medications, steroid creams and light therapy . Drugs used Tacrolimus, Hydrocortisone, Dexamethasone, Prednisone